Llwytho...
Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim
OBJECTIVES: Eumycetoma is currently treated with a combination of itraconazole therapy and surgery, with limited success. Recently, olorofim, the lead candidate of the orotomides, a novel class of antifungal agents, entered a Phase II trial for the treatment of invasive fungal infections. Here we de...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Antimicrob Chemother |
|---|---|
| Prif Awduron: | , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7069493/ https://ncbi.nlm.nih.gov/pubmed/31904836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkz529 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|